|
|
Event Archives
Healthcare IT
The Washington Biotechnology & Biomedical Association (WBBA) was proud to present Healthcare IT (HIT) on Wednesday, August 25, 2010. HIT provides for the comprehensive management of health information and its secure exchange between consumers, providers, government and quality entities, and insurers. HIT is a promising tool for improving the overall quality, safety and efficiency of the health delivery system. The Administration has invested $19 billion from the economic stimulus program to support electronic medical records, yet most healthcare providers, let alone consumers, are still struggling to adopt technologies that promise to deliver on a new era of more efficient, personalized healthcare.
WBBA brought together some of the region's experts in software and emerging technologies who are driving HIT innovations to create more effective new medicines, help consumers take better control of their wellness, and enable providers to deliver healthcare more efficiently.
The dynamic and interactive panel discussion, highlighted how IT is changing healthcare, and what hurdles still exist before the era of personalized medicine and care can be realized. Discussion included ways in which HIT can make a meaningful contribution to healthcare quality.
Our panel was led by moderator Eric Schadt, Ph.D, Chief Scientific Officer, at Pacific Biosciences. Panelists included:
Jac Davies, Director, Beacon Community of the Inland Northwest, Inland Northwest Health Services
Stephen H. Friend MD PhD, President and Co-Founder, Sage Bionetworks
Rod Hochman, Chief Executive Officer, Swedish Medical Center
Jim Karkanias, Partner and Senior Director of Applied Research and Technology, Microsoft Corporation
Erik Nillsson, President, Insilicos
Thank you to Microsoft for their generous sponsorship of this event. 
8/30/10 Thea Chard of Xconomy reports on the WBBA HIT program: Electronic Data Sharing, Cloud-Computing, and Collaboration: The WBBA Talks on the Future of Health IT
Return to top
 When the going (funding) gets tough, the tough go shopping (for grants and contracts). As NIH success rates enter single digits and venture capital funding diminishes, academic investigators and small companies collaborate to obtain federal small business funds (SBIR and STTR). WBBA was please to host Gregory Milman, Ph.D., Director of the Office for Innovation and Special Programs in the National Institute of Allergy and Infectious Diseases (NIAID) as he led a workshop on August 3, at Zymogenetics, in Seattle and on August 4, at SIRTI, in Spokane.
 Dr. Milman discussed, among other topics, real NIH funding limits, success rates for NIH applications, how to write for NIH review criteria, and how academic investigators can tap into NIH funds. In Seattle, he led a panel of local NIH grant recipients in a discussion that highlighted the panelists’ strategies for producing winning proposals.
Review Dr. Milman’s presentation slides.
Return to top
Summer Social 2010
  Fun in the sun! The Shilshole Bay Beach Club and the best weather of the year combined with fantastic and fun sponsor displays and over 250 life science friends to make the WBBA's 12th Annual Summer Social the best ever!
Thank you to our generous and creative sponsors: Airgas, BarclayDean Environments, BNBuilders, Employer Resources NW, Fenwick & West, Graphica, Lab Research Inc., Lilly USA, LLC, MedIntellibase, Praxair, Puget Sound Bank, Seed IP Law Group PLLC, and Wells Fargo Insurance Services.
The music of the steel drum band set the island mood and we have pictures to prove it! Don't miss the fun next year!
Return to top
Pub Night- Bellevue
On June 3rd, Pub Night festivities moved to Bellevue where 45 life science colleagues got together for networking and cocktails at the Bellevue Grill. If you have a venue idea for a WBBA Pub Night, please contact Darcy Jacobson. Don't miss the fun at the October 7 Pub Night. Mark your calendar!
Return to top
Domesticating Global Health: "Domestic Companies with Global Health Impact"
The third installment of the Domesticating Global Health series: "Domestic Companies with Global Health Impact" was held on May 25 at Seattle Biomedical Research Institute (SBRI).
The distingushed panel of experts, moderated by Lisa Cohen, MA, Director, Washington Global Health Alliance included:
Anne Bugge,Vice President, Global Public Health, Sonosite
Karen Hedine, President & CEO, Micronics, Inc.
John Kaestle, President & CEO, HaloSource
Discussion centered on ways to better position Washington state as a Global Health Epi-Center and leverage the global health community. With the support of Global Health Nexus Seattle, WBBA is pleased to offer this event via webcast. View it online now!
Thank you to the event sponsors: BNBuilders, City of Seattle Office of Economic Development, Washington Global Health Alliance. and our host Seattle BioMed.
Don't miss part four of the series on November 10: "Closing the Gap."
Return to top
Business with Asia
 This program from WBBA's Business Development Series focused on Washington state's continued expansion of our Asian trade relationship and the budding partnership opportunities for life science companies in the Asian market. This event was designed to provide access to and engage prospective relations for Washington organizations who wish to partner and access capital from China, Japan, Korea and Taiwan. Case studies of companies that have successfully completed alliances in the East were presented.
A panel of experts was led by Moderator Susan Wang, PhD, Strategic Director - Asia and Chief Representative / Shanghai Rep Office for Ricerca Biosciences (formally MDS Pharma).
Panelists Included:
David Fanning, President & CEO, Theraclone Sciences
Ryo Kubota, M.D., Ph.D. Chairman, President & CEO, Acucela
Biaoyang Lin, Ph.D., Research Scientist, Swedish Neuroscience Institute & Professor and Director, Systems Biology, Zhejiang-California International Nanosystems Institute (ZCNI), Hangzhou, China
Daniel Liao, Director General, Taipei Economic and Cultural Office, Seattle
Takashi Nagao, President, Mitsubishi Tanabe Pharma America, Inc.
Return to top
In a program designed to highlight the state’s most innovative discoveries, technologies and innovation that Washington has to offer, four panelists discussed the opportunities and challenges of biomass development as part of the WBBA’s Breakfast for Success Life Science Innovation Series.
Alternative fuels produced from algae, seaweed and other natural sources may result in substantial benefit to the Northwest, including treatment of industrial wastewater, increased crop production and growing synergy between the life sciences and information technology.
The trick is to find and fund commercialization strategies that recognize customer-driven needs and a defined route to the market place.
The panelists were Margaret McCormick, general manager, bio-based materials for Targeted Growth; Rick LeFaivre of the University of Washington Center for Commercialization; Rose Ann Cattolico, a UW research biologist; and Linda Beltz, director of Technology Partnerships/Open Innovation at Weyerhaeuser. The discussion was moderated by John Gardner, vice president of Washington State University’s Office of Economic Development and Extension and a member of the Washington Clean Energy Leadership Council, and helping to lead the charge for alternative energy technologies in Washington state. Read the event summary.
Return to top
The Pike Place Brewery was the place to be on April Fool's Day. Sixty-eight industry colleagues came together to network and enjoy a tasty pint! Register today for the next Pub Night- June 3 at the Bellevue Grille at the Bellevue Sheraton!
Return to top
Hundreds from the life sciences community from 15 states, Washington, D.C., and seven countries -- Australia, Canada, China, Denmark, Germany, Japan and the United Kingdom -- attended Life Science Innovation Northwest held March 16 and 17 in Seattle.
“We’re extremely pleased that so many outstanding professionals attended this year’s event,” said Chris Rivera, President, Washington Biotechnology & Biomedical Association. “It demonstrates continued growth in the life sciences industry and a growing global understanding that Washington state is taking its place among top leaders in innovation."
Attendees were treated to two days of panel discussions, a state-of-the-industry report by G. Steven Burrill, CEO of Burrill & Company, the keynote address by Rajiv Shah, administrator of the U.S. Agency for International Development, and presentations by life science companies and leading research and global health organizations.
Burrill & Company joined WBBA to co-sponsor this year's event.
Learn more about the 2010 event from a Special Edition of The Life Science Innovator newsletter.
Return to top
Led by moderator Ulrich Mueller, Ph.D., Vice President, Fred Hutchinson Cancer Research Center, panelists explored the differences between academia and industry. The interactive program addressed questions from the diverse audience on topics such as career opportunities and how to prepare for them and how to get your foot in the door. The team of experienced executives described what a biotech job looks like and how to evaluate if you’re ready for the transition.
Thank you to our panelists:
Michael Gallatin, Ph.D., President and Co-founder, Calistoga Pharmaceuticals, Jonathan Drachman, M.D., Vice President, Translational Medicine at Seattle Genetics and Kenneth Ferguson, Ph.D., President and CEO, Imvaxyn, Inc.
Our generous and gracious host was Fred Hutchinson Cancer Research Center.
Return to top
The event was held on February 10 at Seattle Biomedical Research Institute (SBRI).
The distingushed panel of experts included:
Bernhard H Weigl, PhD, MSc, Group Leader, Diagnostic Development Teams, PATH- View Presentation Slides
Craig Rubens, MD, PhD - Children’s Hospital of Seattle; Executive Director, GAPPS
Curt Malloy, JD, PRH, President, Infectious Disease Research Institute (IDRI)- View Presentation Slides
Barry Lutz, PhD - University of Washington, Department of Bioengineering- View Presentation Slides
Lisa Cohen, Washington Global Health Alliance – Moderator
Discussion centered on Washington state as a nexus for global health research and development. Low-cost, effective devices and diagnostics designed here are transforming healthcare worldwide, especially in developing countries who are most in need of help. In the second of the four-part series; “Domesticating Global Health”, our expert panel highlighted several innovative technologies that are being developed for the Global Health community, many of which will also have domestic applications here at home.
Thank you to the event sponsors: BNBuilders, City of Seattle Office of Economic Development, Washington Global Health Alliance. and our host SBRI.
Don't miss part three of the series on May 26: "Domestic Companies with Global Health Impact."
Return to top
WBBA kicked the year off with Bio on the Vine (aka "Pub Night") on January 19 at Fortunato's Wine Bar in Woodinville. Distinguished speaker Thomas Henick-Kling, PhD. gave a riveting presentation entitled "Microbes and Wine Quality - Are microorganisms the tool to let wines express their regional identity (terroir) or are they the foe?" to a packed house.
Dr. Henick-Kling is the Director of the Wine Science Program and Professor of Enology at Washington State University. Henick-Kling is a wine microbiologist and has commercial and experimental winemaking experience and extensive knowledge of wines from Europe, USA, Australia and New Zealand. He is active in several national and international professional societies. He is a wine judge and a reviewer for several scientific journals.
Thank you to our host Fortunato's Wine Bar.
Return to top
Washington's life sciences community joined WBBA for our 2009 Annual Meeting on November 6 in Seattle.
The program featured Dr. Elias Zerhouni, former Director of the National Institute of Health, presenting "Translational Research and Global Health: the Impact on Washington State." View Dr. Zerhouni's presentation slides.
We Work for Health provided a report on its Life Science Economic Impact Study and the WBBA followed with a report on our progress in 2009, our current challenges and the coming opportunities in life sciences locally, nationally and globally.
WBBA thanks our sponsors that helped us make this event a success!
Return to top
|
Event Archives
2010
2009
|
